MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.
about
Chromosome 21-Encoded microRNAs (mRNAs): Impact on Down's Syndrome and Trisomy-21 Linked Disease.A microRNA cluster (let-7c, miRNA-99a, miRNA-125b, miRNA-155 and miRNA-802) encoded at chr21q21.1-chr21q21.3 and the phenotypic diversity of Down's syndrome (DS; trisomy 21)miR-155 mediates arsenic trioxide resistance by activating Nrf2 and suppressing apoptosis in lung cancer cells.Mechanisms of Drug Resistance in Cancer: The Role of Extracellular Vesicles.Cisplatin induces the release of extracellular vesicles from ovarian cancer cells that can induce invasiveness and drug resistance in bystander cells.MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagy.Exosome-mediated breast cancer chemoresistance via miR-155 transfer.Extracellular vesicles as mediators of the progression and chemoresistance of pancreatic cancer and their potential clinical applications.miR-155 in cancer drug resistance and as target for miRNA-based therapeutics.Five key lncRNAs considered as prognostic targets for predicting Pancreatic Ductal Adenocarcinoma.The role of miRNAs in the diagnosis, chemoresistance, and prognosis of pancreatic ductal adenocarcinoma.Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.Patients Treated with Preoperative Chemoradiation for Pancreatic Ductal Adenocarcinoma have Impaired Bone Density, a Predictor of Distant Metastasis.The role of exosomal non-coding RNAs in cancer metastasis.Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage.Functional miRNAs in breast cancer drug resistance.Liquid biopsy in pancreatic cancer: the beginning of a new era.Role of exosomes in pancreatic cancer.microRNA based prognostic biomarkers in pancreatic Cancer.
P2860
Q39422078-2C6622D5-8B21-47FA-B048-84CDFBED3DCFQ41689316-F29F9253-C60A-4B7D-BC84-25F644595EF7Q41959235-1D8D04AD-FBB4-4624-931F-5C1FAC136CFFQ46088676-43E3C4BB-3371-44F7-B08A-08ADF3241DA8Q46538048-B1419191-B2FF-4B23-B57A-4BC4888BD161Q47107545-7CEE9A9F-8824-4B7C-984F-2CBC8D90C518Q48231556-29D8075E-616F-4646-A0C3-EAEDD5829DBCQ48301473-CE3592AF-FE9C-4CE5-9F4A-7B51B4DD5FEEQ49544999-D063A181-A913-467E-B559-1177258023DAQ49852516-1B56D04C-93BF-4117-B6AF-08B4BB7421BBQ50129161-3B1B1BC4-C05C-423A-A46C-FC60126BA201Q50252299-64FF20EC-BC8F-4148-90EF-911CB407C358Q50493922-96595635-08CE-4EC5-87D1-871CAA9C89C9Q52649575-E094777C-3AA8-4FD9-BB52-EBE0FC16CB52Q53689677-4CF3ABE2-2248-4F1C-9FB0-D3B06DAB995CQ55000578-4CA53FFE-1F13-46B2-88DE-828F7FA7DC21Q55187959-B323944A-8900-4E9C-8B86-7200A085258BQ55259893-751CE937-A184-4999-A749-C39709A29CCEQ55344720-4AED35B3-1C36-4497-ADA4-93F615A70F00
P2860
MicroRNA-155 Controls Exosome Synthesis and Promotes Gemcitabine Resistance in Pancreatic Ductal Adenocarcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MicroRNA-155 Controls Exosome ...... creatic Ductal Adenocarcinoma.
@en
MicroRNA-155 Controls Exosome ...... creatic Ductal Adenocarcinoma.
@nl
type
label
MicroRNA-155 Controls Exosome ...... creatic Ductal Adenocarcinoma.
@en
MicroRNA-155 Controls Exosome ...... creatic Ductal Adenocarcinoma.
@nl
prefLabel
MicroRNA-155 Controls Exosome ...... creatic Ductal Adenocarcinoma.
@en
MicroRNA-155 Controls Exosome ...... creatic Ductal Adenocarcinoma.
@nl
P2093
P2860
P356
P1433
P1476
MicroRNA-155 Controls Exosome ...... creatic Ductal Adenocarcinoma.
@en
P2093
Daisaku Yamada
Hidetoshi Eguchi
Hiroshi Wada
Koichi Kawamoto
Kunihito Gotoh
Manabu Mikamori
Masahiro Tanemura
Shinichiro Hasegawa
Tadafumi Asaoka
Takehiro Noda
P2860
P2888
P356
10.1038/SREP42339
P407
P577
2017-02-15T00:00:00Z